Business

TempraMed Strengthens Global Intellectual Property Position with Grant of South Korean Patent

HighlightsNewly granted patent protects TempraMed's VIVI Box™ proprietary, hassle-free thermal-insulation system and smart-monitoring architectureExpands the Company's ability to adapt its core technology to a wider range of drug categories-from chronic self-injectables to complex biologicsEnhances commercialization opportunities and supports strategic engagement with leading appliance manufacturers in Asia's premium refrigeration marketVancouver, British Columbia--(Newsfile Corp. - December 15,

articleTempramed Technologies Ltd.December 15, 20253/company/tempramed-technologies-ltd/news/tempramed-strengthens-global-intellectual-property-position-with-grant-of-south-korean-patent
TempraMed Strengthens Global Intellectual Property Position with Grant of South Korean Patent

About this update from Tempramed Technologies Ltd.

[{"type":"text","content":"Highlights","length":10,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Newly granted patent protects TempraMed's VIVI Box™ proprietary, hassle-free thermal-insulation system and smart-monitoring architecture","length":140,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Expands the Company's ability to adapt its core technology to a wider range of drug categories-from chronic self-injectables to complex biologics","length":149,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Enhances commercialization opportunities and supports strategic engagement with leading appliance manufacturers in Asia's premium refrigeration market","length":154,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":443,"olType":false},{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - December 15, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce that it has been granted an additional allowed patent in South Korea, issued under Korean Patent Application No. 10-2021-7011422.","length":429,"tagName":"p"},{"type":"text","content":"The newly granted patent covers, among other features, the Company's new product category, VIVI Box™, a consumer-focused medical-storage system engineered to keep temperature-sensitive medications safe within domestic refrigerators. The system prevents freezing, stabilizes medication temperatures, and maintains a secure 8°C environment for up to 24 hours without external power. VIVI Box™ provides uninterrupted protection during routine use, travel, transportation, or unexpected power outages. Designed to support fast-growing medication categories including insulin, GLP-1 therapies, biologics, and other specialty drugs, VIVI Box™ offers a dependable, reusable solution that bridges the gap between pharmacy cold-chain requirements and real-world patient behavior.","length":774,"tagName":"p"},{"type":"text","content":"Without limiting the scope of the patent, it includes capabilities such as:","length":75,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Continuous temperature protection during power interruption...

More updates from Tempramed Technologies Ltd.

TempraMed Technologies Ltd.CompanyVIVITempraMedmedicationstemperature fluctuations